Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis

Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis is an SME in Vari, Greece that has taken part in 9 EU-funded projects since 2008, receiving €2.0M in EU funding.

EU funding received€2.0M
EU projects9
As coordinator0
Running now2
First EU project2008
Latest project2025
CountryGreece
EU registration (PIC)998752741
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.5M · 6 projects
  • Horizon Europe€398k · 2 projects
  • Horizon 2020€91k · 1 project

Projects

9 EU-funded projects, newest first. Each links to the official record.

  • PRIM-TECH3RPartner

    Preclinical in vitro Models for the Replacement, Reduction and Refinement of Mouse Models in Preclinical Studies (PRIM-TECH3R)

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €177ktheir share
  • INFRAPLUSPartner

    Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €222ktheir share
  • INFRAFRONTIER2020Partner

    Towards enduring mouse resources and services advancing research into human health and disease

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €91ktheir share
  • CodeAgePartner

    The role of Chronic DNA damage in Ageing and Age-related pathology

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €222ktheir share
  • ADDRESSPartner

    Joint training and research network on Chromatin Dynamics and the DNA Damage Response

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €230ktheir share
  • TARKINAIDPartner

    Targeting Src-family tyrosine kinases in chronic autoimmune and inflammatory diseases

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €178ktheir share
  • BTCUREPartner

    BeTheCuRE

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €99ktheir share
  • INFLA-CAREPartner

    Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €332ktheir share
  • MASTERSWITCHPartner

    Mechanisms to Attack Steering Effectors of Rheumatoid Syndromes with Innovated Therapy Choices

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €413ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • business models
  • databases
  • drug discovery
  • genomes
  • inflammatory diseases
  • microbiology
  • oncology
  • pathology
  • personalized medicine
  • rheumatology

Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime